Relay Therapeutics Q2 Net Income USD -83.707 Million Vs. IBES Estimate USD -74.2 Million
RLAY•Second-quarter results
Aug. 6 (Reuters) - Relay Therapeutics Q2 operating income was USD -90.824 million.
- Q2 revenue was USD 350 thousand vs. IBES estimate USD 872.7 thousand
- Q2 operating expenses were USD 91.174 million
- Q2 basic EPS was USD -0.41
- Q2 EPS was USD -0.41
